You can purchase shares of GENOMMA LAB INTL SAB ORD by Genomma Lab International SAB DE CV (OTCPK:GNMLF) through any online brokerage.
There are no as such competitors for GENOMMA LAB INTL SAB ORD by Genomma Lab International SAB DE CV.
There is no analysis for GENOMMA LAB INTL SAB ORD by Genomma Lab International SAB DE CV to provide a consensus price target.
The stock price for GENOMMA LAB INTL SAB ORD by Genomma Lab International SAB DE CV (OTCPK: GNMLF) is $0.7548 last updated October 30, 2026 at 9:52 AM EDT.
There are no upcoming dividends for GENOMMA LAB INTL SAB ORD by Genomma Lab International SAB DE CV.
GENOMMA LAB INTL SAB ORD by Genomma Lab International SAB DE CV does not have any upcoming earnings scheduled.
There is no upcoming split for GENOMMA LAB INTL SAB ORD by Genomma Lab International SAB DE CV.
GENOMMA LAB INTL SAB ORD by Genomma Lab International SAB DE CV is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide...